Home » Topics » BioWorld Science

BioWorld Science
RSS

New necroptosis inhibitors synthesized at Anaxis Pharma

Sep. 22, 2021

Fochon Pharmaceuticals describes CDK2/CDK4/CDK6 inhibitors

Sep. 22, 2021

Sichuan Kelun-Biotech Biopharmaceutical presents new PPAR receptor agonists

Sep. 22, 2021

Dual SYK/VEGFR2 inhibitors discovered at Ocumension Therapeutics

Sep. 22, 2021

Pelareorep shows synergistic effect with radiotherapy in basal-like breast cancer

Sep. 22, 2021

Kyoto University develops sequence-selective mitochondrial DNA alkylators for mitochondrial diseases

Sep. 22, 2021

Mouse models, MOS models, organoids can make personalized predictions

Sep. 21, 2021

Trigone Pharma collaborates with 4C Biomed on intravesical immunotherapy for bladder cancer

Sep. 21, 2021

Virpax acquires rights to Nanomerics' technology to deliver intranasal cannabidiol product

Sep. 21, 2021

KLF5 inhibitor AM-80 ameliorates muscular atrophy in mice

Sep. 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...